Table 2.
CpG identifier | Chr | Position | OR | 95% CI | P | FDR | Gene name | Gene position |
---|---|---|---|---|---|---|---|---|
cg19693031 | 1 | 144152909 | 0.52 | 0.46–0.6 | 2.7E-21 | 1.3E-15 | TXNIP | 3′ UTR |
cg06500161 | 21 | 42529656 | 1.65 | 1.45–1.89 | 6.4E-14 | 1.5E-08 | ABCG1 | Body |
cg14476101 | 1 | 120057515 | 0.67 | 0.59–0.76 | 2.8E-10 | 3.9E-05 | PHGDH | Body |
cg14020176 | 17 | 70276580 | 1.63 | 1.4–1.9 | 3.3E-10 | 3.9E-05 | SLC9A3R1 | 3′ UTR |
cg11024682 | 17 | 17670819 | 1.56 | 1.35–1.79 | 6.0E-10 | 5.7E-05 | SREBF1 | Body |
cg06397161 | 22 | 38090005 | 1.51 | 1.32–1.73 | 4.5E-09 | 3.3E-04 | SYNGR1 | Body; TSS200 |
cg00574958 | 11 | 68364198 | 0.69 | 0.61–0.78 | 5.2E-09 | 3.3E-04 | CPT1A | 5′ UTR |
cg06235429 | 11 | 67129690 | 1.49 | 1.3–1.7 | 5.5E-09 | 3.3E-04 | NDUFV1 | TSS1500 |
cg05778424 | 17 | 52524507 | 1.69 | 1.42–2.02 | 7.4E-09 | 3.9E-04 | AKAP1 | 5′ UTR |
cg11376147 | 11 | 57017774 | 0.68 | 0.59–0.77 | 1.3E-08 | 6.0E-04 | SLC43A1 | Body |
cg04816311 | 7 | 1033176 | 1.51 | 1.31–1.75 | 1.7E-08 | 7.2E-04 | C7orf50 | Body |
cg02711608 | 19 | 51979804 | 0.69 | 0.6–0.79 | 4.5E-08 | 1.5E-03 | SLC1A5 | 1st exon; 5′ UTR |
cg08309687 | 21 | 34242466 | 0.68 | 0.6–0.78 | 4.5E-08 | 1.5E-03 | ||
cg13514042 | 7 | 1158728 | 1.42 | 1.25–1.61 | 4.5E-08 | 1.5E-03 | ||
cg08994060 | 10 | 6254032 | 0.65 | 0.55–0.76 | 5.2E-08 | 1.6E-03 | PFKFB3 | Body |
cg01676795 | 7 | 75424284 | 1.56 | 1.33–1.84 | 6.5E-08 | 1.8E-03 | POR | Body |
cg25130381 | 1 | 27313308 | 1.49 | 1.29–1.73 | 6.7E-08 | 1.8E-03 | SLC9A1 | Body |
cg11183227 | 15 | 89256411 | 1.49 | 1.29–1.72 | 7.0E-08 | 1.8E-03 | MAN2A2 | Body |
Position: by HapMap build 37. OR: odds ratio per 1 SD in methylation intensity. Genes: gene names in which the CpG falls from 1,500 bp upstream of the transcriptional start site to the end of the 3′ UTR as in Illumina’s Infinium Human Methylation 450K BeadChip manifest file. Chr, chromosome; FDR, false discovery rate.